Cost-Minimisation Study of Dorzolamide versus Brinzolamide in the Treatment of Ocular Hypertension and Primary Open-Angle Glaucoma
- 1 January 2003
- journal article
- clinical trial
- Published by Springer Nature in PharmacoEconomics
- Vol. 21 (3) , 201-213
- https://doi.org/10.2165/00019053-200321030-00005
Abstract
Objective:Cost is an issue when prescribing two drugs with equivalent efficacy. We compared the direct medical costs of topical brinzolamide 1% (twice a day or three times daily) with topical...Keywords
This publication has 42 references indexed in Scilit:
- Comparisons of Intraocular-Pressure- Lowering Efficacy and Side Effects of 2% Dorzolamide and 1% BrinzolamideOphthalmologica, 2001
- The long-term safety and efficacy of brinzolamide 1.0% (Azopt) in patients with primary open-angle glaucoma or ocular hypertensionAmerican Journal of Ophthalmology, 2000
- Ocular Comfort of Brinzolamide 1.0% Ophthalmic Suspension Compared With Dorzolamide 2.0% Ophthalmic Solution: Results From Two Multicenter Comfort StudiesSurvey of Ophthalmology, 2000
- The Efficacy and Safety of Brinzolamide 1% Ophthalmic Suspension (Azopt®) as a Primary Therapy in Patients With Open-Angle Glaucoma or Ocular HypertensionSurvey of Ophthalmology, 2000
- Clinical efficacy and safety of brinzolamide (Azopt™), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertensionAmerican Journal of Ophthalmology, 1998
- Prevalence of open‐angle glaucoma in central SwedenActa Ophthalmologica Scandinavica, 1996
- Medical treatment of glaucoma and the promising perspectivesCurrent Opinion in Opthalmology, 1996
- The Economic Burden of Glaucoma in the UKPharmacoEconomics, 1995
- Myopia and glaucomaAlbrecht von Graefes Archiv für Ophthalmologie, 1980
- The management of elevated intraocular pressure with normal optic discs and visual fieldsSurvey of Ophthalmology, 1977